LIPOSOMAL AMPHOTERICIN B (L-AMB) TWICE WEEKLY AS ANTIFUNGAL PROPHYLAXIS IN PEDIACTRIC CANCER PATIENTS

被引：0
|
作者：
Lehrnbecher, Thomas [1 ]
Schedler, Nadine [1 ]
Tramsen, Lars [1 ]
Becker, Martina [1 ]
Klingebiel, Thomas [1 ]
Bochennek, Konrad [1 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2010年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：948 / 949
页数：2
相关论文
共 50 条
  • [41] Single large dose (15 Mg/Kg) amphotericin B lipid complex (L-AmB) as prophylaxis of fungal infections during induction chemotherapy in acute non lymphoid leukemia (ANLL).
    Chierichini, A
    Fenu, S
    Persiani, M
    Cortese, S
    Cassetta, MI
    Novelli, A
    Annino, L
    BLOOD, 2005, 106 (11) : 231B - 232B
  • [42] Comparison of caspofungin versus liposomal amphotericin B as antifungal prophylaxis following allogeneic hematopoietic stem cell transplantation in paediatric patients
    Doering, M.
    Lang, P.
    Handgretinger, R.
    Mueller, I
    ONKOLOGIE, 2010, 33 : 69 - 70
  • [43] Prophylaxis of pulmonary mycosis with intravenous amphotericin B (AmB) in patients with acute myelogenous leukemia (AML).
    Boehme, A
    Hoelzer, D
    BLOOD, 1999, 94 (10) : 47B - 47B
  • [44] Liposomal amphotericin B (L-AMB) as initial therapy for invasive filamentous fungal infections (IFFI): A randomized, prospective trial of a high loading regimen vs. standard dosing (AmBiLoad trial).
    Cornely, OA
    Maertens, J
    Bresnik, M
    Herbrecht, R
    BLOOD, 2005, 106 (11) : 900A - 900A
  • [45] Low-dose liposomal amphotericin B for antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell transplantation
    Mendoza-Palomar, Natalia
    Soques, Elena
    Isabel Benitez-Carabante, Maria
    Gonzalez-Amores, Miriam
    Fernandez-Polo, Aurora
    Renedo, Berta
    Teresa Martin, Maria
    Soler-Palacin, Pere
    Diaz-de-Heredia, Cristina
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (08) : 2264 - 2271
  • [46] Liposomal amphotericin B followed by voriconazole for secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients
    Allinson, K.
    Kolve, H.
    Gumbinger, H. G.
    Vormoor, H. J.
    Ehlert, K.
    Groll, A. H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S258 - S258
  • [47] Antifungal prophylaxis with micafungin and bridging to inhaled liposomal amphotericin B after engraftment in patients undergoing allogeneic hematopoietic stem cell transplantation
    Rivera, D.
    De Ramon, C.
    Avendano, A.
    Carrillo, J.
    Caballero, D.
    Lopez, L.
    Ormazabal, I.
    Navarro, A.
    Martin, A.
    Vazquez, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S240 - S240
  • [48] Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center
    Mrig, Sumit
    Sardana, Kabir
    Arora, Pooja
    Narula, Vineet
    Arora, Sandeep
    Kapoor, Amrit
    Baruah, Ritu Raj
    Sen, Poornima
    Agarwal, Shweta
    Sachdeva, Soumya
    Dewan, Arun
    Panesar, Sanjeet
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (03)
  • [49] Aerosolized Liposomal Amphotericin B: A Potential Prophylaxis of Invasive Pulmonary Aspergillosis in Immunocompromised Patients
    Kamalaporn, Harutai
    Leung, Kitty
    Nagel, Mark
    Kittanakom, Saranya
    Calvieri, Battista
    Reithmeier, Reinhart A. F.
    Coates, Allan L.
    PEDIATRIC PULMONOLOGY, 2014, 49 (06) : 574 - 580
  • [50] Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit
    Fumarola, Benedetta
    Signorini, Liana
    Lorenzotti, Silvia
    Lanza, Paola
    Saccani, Barbara
    Van Hauwermeiren, Evelyn
    Mule, Alice
    Piva, Simone
    Rota, Matteo
    Zuccala, Francesco
    Rasulo, Francesco Antonio
    Filippini, Matteo
    Bertazzoli, Alberto
    Del Fabro, Giovanni
    Matteelli, Alberto
    INFECTION, 2024, 52 (04) : 1459 - 1468
12345